Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-09T14:26:37.070Z Has data issue: false hasContentIssue false
  • English
  • Français

Alleviating the social, health, and economic costs of apathy in dementia

Commentary on “Cost Consequence Analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)” by Lanctôt et al.

Published online by Cambridge University Press:  27 April 2023

Perminder S. Sachdev Open the ORCID record for Perminder S. Sachdev [Opens in a new window]
Perminder S. Sachdev*
Affiliation:
Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, UNSW Sydney, NSW, Australia Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, NSW, Australia
*
Email: [email protected]
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
International Psychogeriatrics , Volume 35 , Special Issue 11: Issue Theme: Neuropsychiatric Symptoms of Mild and Major Neurocognitive Disorders , November 2023 , pp. 608 - 610
Copyright
© International Psychogeriatric Association 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brodaty, H., Altendorf, A., Withall, A. and Sachdev, P. (2010). Do people become more apathetic as they grow older? A longitudinal study in healthy individuals. International Psychogeriatrics, 22, 426–436. https://doi.org/10.1017/S1041610209991335.CrossRefGoogle Scholar
Connors, M. H., Teixeira-Pinto, A., Ames, D., Woodward, M. and Brodaty, H. (2023). Apathy and depression in mild cognitive impairment: distinct longitudinal trajectories and clinical outcomes. International Psychogeriatrics., 30, 1–10. https://doi.org/10.1017/S1041610222001089.CrossRefGoogle Scholar
Cummings, J. et al. (2015). Apathy in neurodegenerative diseases: recommendations on the design of clinical trials. Journal of Geriatric Psychiatry Neurology, 28, 159–173. https://doi.org/10.1177/0891988715573534.CrossRefGoogle ScholarPubMed
Dykstra Goris, E., Ansel, K. N. and Schutte, D. L. (2016). Quantitative systematic review of the effects of non-pharmacological interventions on reducing apathy in persons with dementia. Journal of Advance Nursing, 72, 2612–2628. https://doi.org/10.1111/jan.13026.CrossRefGoogle Scholar
Feast, A., Moniz-Cook, E., Stoner, C., Charlesworth, G. and Orrell, M. (2016). A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well-being. International Psychogeriatrics, 28, 1761–1774. https://doi.org/10.1017/S1041610216000922.CrossRefGoogle ScholarPubMed
Harrison, F., Aerts, L. and Brodaty, H. (2016). Apathy in dementia: systematic review of recent evidence on pharmacological treatments. Current Psychiatry Reports, 18, 103. https://doi.org/10.1007/s11920-016-0737-7.CrossRefGoogle ScholarPubMed
Herrmann, N. and Lanctôt, K. L. (2007). Pharmacotherapy of apathy in dementia: a systematic review of the evidence. Journal of Neuropsychiatry and Clinical Neurosciences., 19, 247–254. https://doi.org/10.1176/jnp.2007.19.3.247.Google Scholar
Herrmann, N. et al. (2006). The contribution of neuropsychiatric symptoms to the cost of dementia care. International Journal of Geriatric Psychiatry., 21, 972–976. https://doi.org/10.1002/gps.1594.CrossRefGoogle Scholar
Kishi, T., Sakuma, K. and Iwata, N. (2020). Efficacy and safety of psychostimulants for Alzheimer’s disease: a systematic review and meta-analysis. Pharmacopsychiatry, 53, 109–114. https://doi.org/10.1055/a-1076-8228.Google ScholarPubMed
Kruse, C. et al. (2023). Apathy in patients with Alzheimer’s disease is a cost-driving factor. Alzheimer’s & Dementia. https://doi.org/10.1002/alz.12915.CrossRefGoogle ScholarPubMed
Lanctôt, K. L. et al. (2023). Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). International Psychogeriatrics, 1–9. https://doi.org/10.1017/S1041610223000327,CrossRefGoogle ScholarPubMed
Lansdall, C. J. et al. (2019). Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration. Neurology, 92, e1547–e1557. https://doi.org/10.1212/WNL.0000000000007249.CrossRefGoogle ScholarPubMed
Mintzer, J. et al. (2021). Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial. JAMA Neurology, 78, 1324–1332. https://doi.org/10.1001/jamaneurol.2021.3356.CrossRefGoogle ScholarPubMed
Mortby, M. E. et al. (2022). Apathy as a treatment target in Alzheimer’s disease: implications for clinical trials. American Journal of Geriatric Psychiatry., 30, 119–147. https://doi.org/10.1016/j.jagp.2021.06.016.CrossRefGoogle ScholarPubMed
Nguyen, J. P. et al. (2018). Efficacy of transcranial direct current stimulation combined with cognitive training in the treatment of apathy in patients with Alzheimer’s Disease: study protocol for a randomized trial. Reviews of Recent Clinical Trials, 13, 319–327. https://doi.org/10.2174/1574887113666180416153316.CrossRefGoogle ScholarPubMed
Padala, P. R. et al. (2018). Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment: a double-blind, randomized, sham-controlled, cross-over pilot study. Psychiatry Research, 261, 312–318. https://doi.org/10.1016/j.psychres.2017.12.063.CrossRefGoogle ScholarPubMed
Padala, P. R. et al. (2020). Neuromodulation for apathy in Alzheimer’s disease: a double-blind, randomized, sham-controlled pilot study. Journal of Alzheimer’s Disease, 77, 1483–1493. https://doi.org/10.3233/JAD-200640.CrossRefGoogle ScholarPubMed
Robert, P. H. et al. (2006). Neuropsychological performance in mild cognitive impairment with and without apathy. Dementia and Geriatric Cognitive Disorders, 21, 192–197. https://doi.org/10.1159/000090766.CrossRefGoogle ScholarPubMed
Sherman, C., Liu, C. S., Herrmann, N. and Lanctôt, K. L. (2018). Prevalence, neurobiology, and treatments for apathy in prodromal dementia. International Psychogeriatrics., 30, 177–184. https://doi.org/10.1017/S1041610217000527.CrossRefGoogle ScholarPubMed